Kayothera, Inc. ("Kayothera"), a preclinical therapeutics company developing first-in-class, small molecule inhibitors of the ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced positive results from its Phase 1 trial evaluating ...
Duke University scientists have discovered that pancreatic alpha cells, long believed to only produce glucagon, actually ...
The agency said infections from NDM-CRE bacteria, which are resistant to “some of the strongest antibiotics available,” are ...
AT least 25 people have died after drinking 90p bottles of bootleg vodka laced with methanol. A nursery school teacher has ...
A new investigational treatment targets the root cause of a life-threatening liver condition connected to obesity and diabetes, offering hope for millions of patients. Scientists at the, San Diego Sch ...
A new study led by Stephen Withers from the University of British Columbia introduces a technique for engineering much more ...
Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of USD 6 ...
Power. Lies. Corruption. David Tennant & Robert Carlyle lead an all-star cast in this explosive true crime drama about the ...
Noonan syndrome with multiple lentigines (NSML) is a rare genetic disorder that causes short stature, distinctive facial ...
Aging, neurological diseases and our bodies' stress response are all linked to the tiny power plants inside each cell known ...
News-Medical.Net on MSN
Blocking iron regulating enzyme triggers cancer cell death in multiple myeloma
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results